CERE — Cerevel Therapeutics Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Cerevel Therapeutics Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG
Status:	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	384	566	892	991
Net Total Receivables	—	—	2.05	5.29
Prepaid Expenses
Total Other Current Assets
Total Current Assets	391	578	906	1,007
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	48.6	51.7	49.3	45.8
Long Term Investments
Other Long Term Assets
Total Assets	445	689	1,018	1,243
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	29.5	42.5	72.6	92.2
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	60.8	110	497	570
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	385	579	521	674
Total Liabilities & Shareholders' Equity	445	689	1,018	1,243
Total Common Shares Outstanding